Courtney Luna
Family · Overland Park, KSNPI 1376243923
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AstraZeneca at 24.3% of the total. 2025 is the largest year on record at $1,676, 2.5 times the $659 reported in 2023. Among family clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 177 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$888
- Sanofi$516
- GSK$363
- Regeneron Healthcare Solutions, Inc.$298
- Takeda Pharmaceuticals U.S.A., Inc.$280
- Novartis$145
- plus $1K from 25 others
What the payments were for
- Consulting fees$180%
- Food & beverage$3,49896%
- Education$1334%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 36 | $888 |
| Sanofi | 28 | $516 |
| GSK | 18 | $363 |
| Regeneron Healthcare Solutions, Inc. | 17 | $298 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $280 |
| Novartis | 7 | $145 |
| CSL Behring | 5 | $131 |
| Kaleo, Inc. | 5 | $115 |
| Grifols USA, LLC | 4 | $105 |
| Hospira, Inc. | 5 | $88 |
| Amgen | 4 | $84 |
| Genentech USA, Inc. | 4 | $61 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $52 |
| Biocryst US Sales Co., LLC | 3 | $51 |
| Blueprint Medicines Corporation | 2 | $43 |
| Greer Laboratories, Inc. | 2 | $38 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| Hikma Pharmaceuticals USA | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Pfizer | 2 | $35 |
| Ionis Pharmaceuticals, Inc. | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Seqirus USA Inc | 1 | $22 |
| Cycle Pharmaceuticals Inc | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| ADMA Biomanufacturing LLC | 1 | $18 |
| Pharming Healthcare, Inc. | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Merck | 1 | $16 |
| LEO Pharma Inc. | 1 | $14 |
How this compares
$3,649 in reported general payments places this provider in the 90th percentile of 1,579 family providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $22,036 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $7,314 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $6,225 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $6,000 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 54 | $1,372 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $1,364 |
| Ipratropium Bromide | 22 | $1,030 |
| Azelastine Hcl | 27 | $667 |
| Montelukast Sodium | 67 | $493 |
| Fluticasone Propionate | 29 | $443 |
| Famotidine | 15 | $285 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $271 |
| Pantoprazole Sodium | 12 | $211 |
| Prednisone | 26 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $363 | $28,26136 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $888 | $13,31425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,579 family providers in Kansas.
Other family in Overland Park
- Jennifer ChesterOverland Park$327K
- Erin FeitzOverland Park$36K
- Tracy GraebenerOverland Park$29K
- Kathryn TimmOverland Park$14K
- Lauren BarberOverland Park$12K
- Tracy HillOverland Park$8K
- Matthew NitschOverland Park$7K
- Gretchen PolandOverland Park$7K
- Anaya KoleOverland Park$7K
- Geneva BealOverland Park$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.